Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Overview01:16

Drug Delivery: Overview

355
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
355
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

933
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
933

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethnopharmacological Validation of Selected <i>Coleus</i> and <i>Plectranthus</i> spp. For Skin-Related Applications Through In Vitro Biological Assays.

Plants (Basel, Switzerland)·2026
Same author

GPX4-Targeting Phenolato Zr<sup>IV</sup> Complexes Induce Ferroptosis and Lysosome-Dependent Cell Death for Immunotherapy of Chemoresistant Cancer.

Journal of medicinal chemistry·2026
Same author

From Virtual Screening to Cell Phenotype: 4-Thiazolidone Scaffolds Targeting LOXL2 in Breast Cancer.

Chemical biology & drug design·2026
Same author

Correction: Ribeiro et al. Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 6728.

International journal of molecular sciences·2026
Same author

Development and Characterization of <i>Mesembryanthemum crystallinum</i> L. Extract-Loaded Phytosomes for Enhanced Delivery of Antioxidant Compounds.

Life (Basel, Switzerland)·2026
Same author

Ultrasound-Assisted Optimization of the Activation and Inactivation of Thermostable α-Amylase.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Aug 17, 2025

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
06:47

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

37.5K

Dehydroroyleanone as a Building Block for a Drug Delivery Platform Based on Self-Assembled Nanoparticles: Structural

Catarina García1,2, Carlos E S Bernardes3, M Fátima M Piedade3,4

  • 1CBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, 1749-024Lisboa, Portugal.

ACS Omega
|December 12, 2022
PubMed
Summary

Researchers developed a novel nanodelivery system using a 6,7-Dehydroroyleanone (DHR)-squalene conjugate. This formulation enhances DHR solubility and bioavailability for potential therapeutic applications.

More Related Videos

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

16.9K
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

8.0K

Related Experiment Videos

Last Updated: Aug 17, 2025

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique
06:47

Formulation of Diblock Polymeric Nanoparticles through Nanoprecipitation Technique

Published on: September 20, 2011

37.5K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

16.9K
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

8.0K

Area of Science:

  • Natural Products Chemistry
  • Nanotechnology
  • Pharmaceutical Sciences

Background:

  • 6,7-Dehydroroyleanone (DHR) is a cytotoxic abietane diterpene found in *Plectranthus* species.
  • DHR exhibits potential therapeutic properties but faces challenges with solubility and bioavailability.

Purpose of the Study:

  • To synthesize and characterize a DHR-squalene conjugate for improved drug delivery.
  • To evaluate the potential of this conjugate as a nanodelivery platform for DHR.

Main Methods:

  • Synthesis of a DHR-squalene conjugate.
  • Analysis using scanning electron microscopy (SEM).
  • Preparation of nanoparticle dispersion in phosphate buffer (pH 7.4).

Main Results:

  • A stable dispersion of DHR-squalene conjugate nanoparticles was successfully produced.
  • The nanodelivery system demonstrated facile production and dispersion characteristics.

Conclusions:

  • The DHR-squalene conjugate nanodelivery platform shows promise for enhancing DHR solubility and bioavailability.
  • This system may enable achievement of therapeutic systemic levels of DHR.